High risk and low prevalence diseases: Acute limb ischemia.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
12 2023
Historique:
received: 05 06 2023
revised: 26 08 2023
accepted: 29 09 2023
medline: 24 11 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: ppublish

Résumé

Acute limb ischemia is a rare but serious condition that carries with it a high rate of morbidity and mortality. This review highlights the pearls and pitfalls of acute limb ischemia, including presentation, diagnosis, and management in the emergency department (ED) based on current evidence. Acute limb ischemia is defined as a sudden decrease in limb perfusion resulting in cessation of blood flow and nutrient and oxygen delivery to the tissues. This leads to cellular injury and necrosis, ultimately resulting in limb loss and potentially systemic symptoms with significant morbidity and mortality. There are several etiologies including native arterial thrombosis, arterial thrombosis after an intervention, arterial embolus, and arterial injury. Patients with acute limb ischemia most commonly present with severe pain and sensory changes in the initial stages, with prolonged ischemia resulting in weakness, sensory loss, and color changes to the affected limb. The emergency clinician should consult the vascular specialist as soon as ischemia is suspected, as the diagnosis should be based on the history and examination. Computed tomography angiography is the first line imaging modality, as it provides valuable information concerning the vasculature and surrounding tissues. Doppler ultrasound of the distal pulses may also be obtained to evaluate for arterial and venous flow. Once identified, management includes intravenous unfractionated heparin and vascular specialist consultation for revascularization. An understanding of acute limb ischemia can assist emergency clinicians in diagnosing and managing this potentially deadly disease.

Identifiants

pubmed: 37844359
pii: S0735-6757(23)00535-1
doi: 10.1016/j.ajem.2023.09.052
pii:
doi:

Substances chimiques

Heparin 9005-49-6

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

152-158

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest NONE. None of the authors have submitted a review on this topic or published previously on this topic.

Auteurs

Jacob Arnold (J)

Department of Emergency Medicine, Brooke Army Medical Center, Fort Sam Houston, TX, USA.

Alex Koyfman (A)

Department of Emergency Medicine, UT Southwestern, Dallas, TX, USA.

Brit Long (B)

Department of Emergency Medicine, Brooke Army Medical Center, Fort Sam Houston, TX, USA. Electronic address: Brit.long@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH